Humana Inc (NYSE:HUM) – Investment analysts at Oppenheimer upped their Q1 2018 EPS estimates for Humana in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn now expects that the insurance provider will post earnings per share of $2.86 for the quarter, up from their previous estimate of $2.72.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The company had revenue of $13.28 billion for the quarter, compared to analyst estimates of $13.41 billion. During the same period in the prior year, the company posted $3.18 EPS. Humana’s quarterly revenue was down 3.0% on a year-over-year basis.

Other equities research analysts have also issued reports about the company. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $297.00 price target for the company in a research note on Monday. Credit Suisse Group assumed coverage on Humana in a research note on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 price target for the company. ValuEngine cut Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Morgan Stanley decreased their target price on Humana from $276.00 to $270.00 and set an “overweight” rating for the company in a research note on Thursday, November 9th. Finally, Cowen reaffirmed a “buy” rating and set a $285.00 target price on shares of Humana in a research note on Wednesday, December 13th. Nine investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $260.10.

Humana (NYSE HUM) traded up $5.58 during mid-day trading on Thursday, hitting $275.75. The company had a trading volume of 1,116,900 shares, compared to its average volume of 1,203,518. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market cap of $38,596.51, a price-to-earnings ratio of 21.70, a P/E/G ratio of 1.69 and a beta of 0.88. Humana has a twelve month low of $186.25 and a twelve month high of $276.07.

Humana announced that its Board of Directors has authorized a stock buyback program on Thursday, December 14th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s management believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s dividend payout ratio is currently 12.59%.

In other news, VP Timothy S. Huval sold 1,382 shares of the stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total transaction of $340,027.28. Following the transaction, the vice president now owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Jody L. Bilney sold 7,054 shares of the stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now directly owns 11,704 shares in the company, valued at approximately $2,901,304.56. The disclosure for this sale can be found here. Insiders have sold a total of 10,115 shares of company stock valued at $2,501,627 over the last ninety days. Company insiders own 0.80% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Creative Planning grew its holdings in shares of Humana by 20.0% during the 4th quarter. Creative Planning now owns 5,864 shares of the insurance provider’s stock worth $1,455,000 after purchasing an additional 977 shares in the last quarter. National Pension Service grew its holdings in shares of Humana by 0.5% during the 4th quarter. National Pension Service now owns 138,188 shares of the insurance provider’s stock worth $34,280,000 after purchasing an additional 658 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Humana by 118.3% during the 4th quarter. Bank of Montreal Can now owns 501,379 shares of the insurance provider’s stock worth $124,378,000 after purchasing an additional 271,701 shares in the last quarter. Convergence Investment Partners LLC grew its holdings in shares of Humana by 7.1% during the 4th quarter. Convergence Investment Partners LLC now owns 12,899 shares of the insurance provider’s stock worth $3,200,000 after purchasing an additional 858 shares in the last quarter. Finally, KCS Wealth Advisory acquired a new stake in shares of Humana during the 4th quarter worth approximately $266,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/01/18/oppenheimer-equities-analysts-lift-earnings-estimates-for-humana-inc-hum.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.